Vancomycin tolerance and dispersion of dual species biofilms of Clostridioides difficile and Vancomycin-resistant Enterococcus faecium

This study demonstrates that while Vancomycin-resistant *Enterococcus faecium* (VRE) inhibits *Clostridioides difficile* biofilm formation in the presence of fermentable glucose, stable dual-species biofilms can be established using non-fermentable sugars without altering vancomycin tolerance, and both single and dual-species biofilms can be dispersed through a nutrient step-change.

The Gist

Imagine your gut as a bustling, crowded city. Inside this city, two notorious troublemakers often hang out together: Clostridioides difficile (C. diff) and Vancomycin-resistant Enterococcus (VRE).

• C. diff is like a chaotic arsonist that causes severe diarrhea and infections, especially after antibiotics wipe out the "good guys" in the city.
• VRE is a tough, armored tank that is already immune to the main weapon doctors use to fight it (vancomycin).

Usually, when these two meet, they just coexist. But this paper asks a fascinating question: What happens when they try to build a fortress together?

In the world of bacteria, a "fortress" is called a biofilm. It's a slimy, sticky community where bacteria stick to a surface (like the gut wall) and build a protective shield around themselves. This shield makes them incredibly hard to kill with antibiotics.

Here is what the scientists discovered, broken down into simple stories:

1. The "Sugar Trap" (Why they can't always build together)

The researchers tried to get these two bacteria to build a biofilm together in a petri dish. They found that the type of "food" (sugar) they ate changed everything.

• The Glucose Disaster: When they fed the bacteria glucose (a common sugar), the VRE tank got to work. VRE eats glucose and turns it into acid (like vinegar). This acid dropped the pH of the environment, making it so sour that the C. diff arsonist couldn't survive. The VRE basically poisoned the construction site, and the C. diff biofilm never got built.
• The Fucose Solution: But, when the scientists switched the food to fucose or xylose (sugars VRE can't turn into acid), the VRE stopped making poison. Suddenly, the two bacteria got along! They built a stable, dual-species fortress together.

The Takeaway: VRE only stops C. diff from building a biofilm if there is too much fermentable sugar around. If you manage the diet, they can coexist in a strong community.

2. The "Unbreakable Shield" (Antibiotic Tolerance)

Doctors use vancomycin to kill C. diff. However, bacteria in a biofilm are like people hiding in a bunker; the medicine can't reach them easily.

The scientists wondered: Does the VRE tank protect the C. diff arsonist?

• In a previous study, a different type of bacteria (sensitive to vancomycin) acted like a "decoy," soaking up the antibiotic and saving C. diff.
• The Result: In this study, the VRE tank did not save the C. diff. Even though VRE is resistant to the drug, it didn't shield its neighbor. C. diff was just as tough (or just as vulnerable) whether it was alone or with VRE. The biofilm itself provided the protection, not the VRE.

3. The "Feast Trigger" (Breaking the Fortress)

Biofilms are great at holding on, but they have a weakness: sudden abundance.

In nature, bacteria sometimes decide to leave their fortress and move to a new location. This is called dispersion. The scientists tested what happens if they suddenly dump a massive amount of fresh, nutrient-rich food onto the biofilm (a 10-fold increase in nutrients).

• The Reaction: The bacteria panicked (in a good way for researchers). The sudden feast triggered an alarm: "There's too much food here! Let's break the walls and go find more!"
• The Result: Both C. diff and VRE broke apart their biofilms and floated away into the liquid.
• The Twist: Just like with the antibiotics, the presence of the other species didn't matter. They both decided to leave at the same time, independently.

Why Does This Matter?

Think of the gut as a city where these bacteria are hiding in bunkers (biofilms) after a war (antibiotic treatment).

1. Diet matters: If we can control what sugars are available in the gut, we might be able to stop these two from teaming up to build a fortress in the first place.
2. The "Feast" Strategy: The discovery that a sudden rush of nutrients makes them leave their bunker is huge. If doctors could trigger this "dispersion" at the exact moment they give antibiotics, they could force the bacteria out of their safe bunker and into the open, where the medicine can actually kill them.

In a nutshell: These two bacteria can build a super-strong team fortress, but only if the diet is right. Once they are in the fortress, they are hard to kill, but a sudden "feast" can trick them into leaving their safety, making them vulnerable again.

Technical Summary

1. Problem Statement

• Clinical Context: Clostridioides difficile (C. difficile) and Vancomycin-resistant Enterococcus faecium (VRE) are frequently co-isolated from patients, particularly in hospital settings. Both pathogens are capable of forming biofilms, which are known to contribute to recurrent infections and antibiotic tolerance.
• Knowledge Gap: While the individual biofilm capabilities of these species are known, their interactions within a dual-species biofilm community remain uncharacterized. Specifically, it is unclear how their metabolic interactions affect biofilm formation, vancomycin tolerance, and the dispersion (disassembly) of the biofilm.
• Specific Challenge: Developing a compatible growth medium for dual-species biofilms is difficult because VRE ferments certain sugars (like glucose) into acids that can inhibit C. difficile growth, complicating the study of their co-existence.

2. Methodology

The study utilized an anaerobic culture system to model dual-species biofilms under controlled conditions.

• Strains: C. difficile (VPI 10463) and VRE (E. faecium ATCC 700223).
• Growth Conditions:
  • Cultures were grown in an anaerobic chamber (90% N₂, 5% CO₂, 5% H₂).
  • Media: Sporulation Media (SM) supplemented with 125 μM deoxycholic acid (DCA) to stimulate biofilm adherence.
  • Carbon Sources: Experiments compared unsupplemented SM, SM + Glucose (fermentable), SM + Fucose, and SM + Xylose (non-fermentable).
  • Surface: 24-well polystyrene plates pre-coated with human fibrinogen to enhance adhesion.
  • Inoculation Ratio: 1:10 (VRE:C. difficile) to account for the faster growth rate of VRE.
• Experimental Assays:
  • Biofilm Formation: Monitored over 48 hours and up to 5 days. Some cultures were static (batch), while others underwent daily media replacement.
  • Quantification: Biofilms were harvested, mechanically disrupted, and plated on selective agar to count Colony Forming Units (CFUs) for each species. pH was measured to monitor acidification.
  • Imaging: Confocal laser scanning microscopy (CLSM) with SYTO-9 staining and COMSTAT analysis were used to visualize macrocolonies and quantify biomass/thickness.
  • Vancomycin Tolerance: 4-day biofilms were treated with 0, 32, or 64 μg/mL vancomycin overnight to assess survival rates.
  • Dispersion Assay: Mature biofilms (grown in 10% SM) were subjected to a "nutrient step-change" by replacing the media with 100% SM for 1 hour. Released cells in the supernatant were enumerated to measure dispersion.

3. Key Contributions

• Establishment of a Dual-Species Model: The authors successfully developed a robust model for C. difficile and VRE co-culture biofilms by identifying that non-fermentable carbon sources (fucose, xylose) or frequent media changes are required to prevent VRE-mediated acidification from killing C. difficile.
• Metabolic Interference Mechanism: The study clarifies that VRE inhibits C. difficile biofilm formation in glucose-rich environments solely through acid production (pH drop), not through direct competition for space or other mechanisms.
• Decoupling of Tolerance and Co-culture: The research demonstrates that the presence of VRE does not alter the intrinsic vancomycin tolerance of C. difficile biofilms, challenging the hypothesis that VRE acts as a "shield" in this specific context.
• Dispersion Trigger Identification: The study identifies a sudden 10-fold increase in nutrient availability as a sufficient trigger to induce dispersion in both mono- and dual-species biofilms.

4. Key Results

• Carbon Source Dependency:
  • Glucose: In the presence of glucose, VRE acidifies the medium (pH ~6.0), leading to a significant reduction in C. difficile CFUs and inhibition of dual-species biofilm formation.
  • Non-Fermentable Sugars (Fucose/Xylose): When glucose was replaced with fucose or xylose, stable dual-species biofilms formed with comparable biomass to mono-species controls. VRE did not inhibit C. difficile growth under these conditions.
• Long-Term Co-culture Dynamics:
  • In static batch cultures with glucose, C. difficile was suppressed.
  • However, daily media replacement allowed C. difficile to recover and reach CFU levels comparable to single-species cultures, even in the presence of glucose. This suggests C. difficile can proliferate during daily cycles of fresh, neutral-pH medium exposure.
• Vancomycin Tolerance:
  • C. difficile biofilms exhibited high tolerance to vancomycin (significant survival at 32 and 64 μg/mL).
  • Crucially, the presence of VRE did not increase or decrease the vancomycin tolerance of C. difficile.
  • Discussion Point: The authors hypothesize that previous studies showing protection by Enterococcus used vancomycin-sensitive strains (which act as "false targets" by binding the drug), whereas the VRE strain used here (resistant) does not bind vancomycin effectively, thus offering no protective "sponge" effect.
• Biofilm Dispersion:
  • A nutrient step-change (10% to 100% SM) induced significant dispersion (release of cells into the supernatant) in both species.
  • There was no significant difference in dispersion rates between mono-species and dual-species biofilms, indicating that the two species regulate dispersion independently in this model.

5. Significance and Implications

• Ecological Insight: The findings highlight the critical role of the gut metabolic environment (specifically carbon source availability and pH) in determining whether C. difficile and VRE can coexist as a biofilm community.
• Therapeutic Resistance: The confirmation that VRE does not protect C. difficile from vancomycin in this model refines our understanding of treatment failure. It suggests that C. difficile biofilm tolerance is an intrinsic property of the biofilm state rather than a result of interspecies shielding by VRE.
• Dispersion as a Therapeutic Target: The discovery that nutrient spikes trigger dispersion is significant. If the regulatory pathways for dispersion can be manipulated, it may be possible to force biofilms to disassemble (releasing planktonic cells) and then treat them with antibiotics, potentially overcoming the high tolerance associated with the biofilm state.
• Future Directions: The authors suggest investigating the effects of specific gut metabolites (bile acids, short-chain fatty acids) on dispersion and comparing VRE with vancomycin-sensitive Enterococcus strains to further validate the "false target" hypothesis regarding antibiotic protection.